skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis

Journal Article · · N.Engl. J. Med.; (United States)

Heart disease in patients with progressive systemic sclerosis may be due in part to myocardial ischemia caused by a disturbance of the coronary microcirculation. To determine whether abnormalities of myocardial perfusion in this disorder are potentially reversible, we evaluated the effect of the coronary vasodilator nifedipine on myocardial perfusion assessed by thallium-201 scanning in 20 patients. Thallium-201 single-photon-emission computerized tomography was performed under control conditions and 90 minutes after 20 mg of oral nifedipine. The mean (+/- SD) number of left ventricular segments with perfusion defects decreased from 5.3 +/- 2.0 to 3.3 +/- 2.2 after nifedipine (P = 0.0003). Perfusion abnormalities were quantified by a perfusion score (0 to 2.0) assigned to each left ventricular segment and by a global perfusion score (0 to 18) for the entire left ventricle. The mean perfusion score in segments with resting defects increased from 0.97 +/- 0.24 to 1.26 +/- 0.44 after nifedipine (P less than 0.00001). The mean global perfusion score increased from 11.2 +/- 1.7 to 12.8 +/- 2.4 after nifedipine (P = 0.003). The global perfusion score increased by at least 2.0 in 10 patients and decreased by at least 2.0 in only 1. These observations reveal short-term improvement in thallium-201 myocardial perfusion with nifedipine in patients with progressive systemic sclerosis. The results are consistent with a potentially reversible abnormality of coronary vasomotion in this disorder, but the long-term therapeutic effects of nifedipine remain to be determined.

Research Organization:
Rene Descartes Univ., Paris, France
OSTI ID:
5428824
Journal Information:
N.Engl. J. Med.; (United States), Vol. 22
Country of Publication:
United States
Language:
English

Similar Records

The effect of captopril on thallium 201 myocardial perfusion in systemic sclerosis
Journal Article · Sun Apr 01 00:00:00 EST 1990 · Clinical Pharmacology and Therapeutics; (USA) · OSTI ID:5428824

Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma
Journal Article · Thu Jan 19 00:00:00 EST 1984 · N.Engl. J. Med.; (United States) · OSTI ID:5428824

Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis
Journal Article · Mon Aug 01 00:00:00 EDT 1988 · Am. J. Med.; (United States) · OSTI ID:5428824